

The BHAT: Propranolol after acute myocardial infarction
This is a Module from the Course

The CARE Trial: Pravastatin reduces risk of coronary events
This is a Module from the Course

The CAST Trial: Anti-arrhythmic agents increase risk of death in patients after myocardial infarction
This is a Module from the Course

The CATIE trial: High rates of medication discontinuation in schizophrenic patients
This is a Module from the Course

The CHADS2 score Trial: Stroke risk in atrial fibrillation
This is a Module from the Course

The CONSENSUS Trial: Enalapril reduces mortality in severe heart failure
This is a Module from the Course

The DASH trial: Diet change significantly reduces blood pressure
This is a Module from the Course

The Device Therapy Landscape Blossoms
This is a Module from the Course

The Device Therapy Landscape Blossoms
This is a Module from the Course

The Device Therapy Landscape Blossoms
This is a Module from the Course

The DIG Trial: Digoxin reduces hospitalization in patients with systolic heart failure
This is a Module from the Course

The ENHANCE trial: Simvastatin and ezetimibe in familial hypercholesterolemia
This is a Module from the Course

The FAME 3 Trial: Fractional Flow Reserve-Guided PCI Compared with Coronary Bypass Surgery
This is a Module from the Course

The FAME 3 Trial: Fractional Flow Reserve-Guided PCI Compared with Coronary Bypass Surgery
This is a Module from the Course

The HMPS II: Characterizing adverse events in hospitalized patients
This is a Module from the Course

The HMPS I trial: Adverse events in patients and negligence
This is a Module from the Course

The HOPE Trial: Ramipril reduces cardiovascular events in high-risk patients with normal ejection fractions
This is a Module from the Course

The HOT trial: Diastolic blood pressure targets in hypertension
This is a Module from the Course